PHONE
+44-7482-878921
+44-7482-878921
2376-0249
Clinical-Medical Image - International Journal of Clinical & Medical Images (2024) Volume 11, Issue 2
Author(s): Amellouk Sara* and Guensi Amal
Department of Nuclear Medicine, University Hospital Center Ibn Rochd, Casablanca, Morocco
Received: 01 February 2024, Manuscript No. ijcmi-24-127075; Editor assigned: 03 February 2024, Pre QC No. P-127075; Reviewed: 15 February 2024, QC No. Q-127075; Revised: 21 February 2024, Manuscript No. R-127075; Published: 29 February 2024, DOI:10.4172/2376-0249.1000942
Citation: Sara A and Amal G. (2024) A Case Report of Lung Cancer Acrometastases Revealed on 18FFDG PET/CT. Int J Clin Med Imaging 11: 942.
Copyright: © 2024 Sara A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Acrometastases (AM) are defined as secondary lesions sited distally to the elbow and knee [1]. The most common primary sites are found in the lung, breast and kidney carcinoma following next in frequency. The presenting sign is often pain unrelieved by ordinary analgesics. The prognosis is often unfavorable, acrometastases are treated by systemic chemotherapy, radiotherapy and amputation [2]. We describe a case of 65 years patient a chronic weaned smoker with a left upper lobar adenocarcinoma that was referred to our institution for initial work up and staging. A whole-body 18Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography scan (PET-CT) revealed acrometastases in the left knee. The patient was treated by radiotherapy for pain relief followed by systemic chemotherapy.
Although the occurrence of AM is rare, whole body acquisition 18F-FDG PET/CT imaging is justified in initial work up and staging of Lung carcinoma due to their impact on prognosis and survival. The real incidence of AM could be much higher considering the risk of unreported cases due to misdiagnosis [3]. Thus, physicians should be updated on AM and their surgical management.
Acrometastases; Fluorodeoxyglucose positron emission tomography-computed tomography; Lung carcinoma
The authors certify that they have obtained all appropriate patient consent forms. In the form, the legal patient has given his consent for images and other clinical information to be reported in the journal.
Nil.
There are no conflicts of interest.
[1] Mavrogenis AF, Mimidis G, Kokkalis ZT, Karampi ES and Papagelopoulos PJ, et al. (2014). Acrometastases. Eur J Orthop Surg Traumatol 24: 279-283.
Google Scholar, Crossref, Indexed at
[2] Spiteri V, Bibra A, Ashwood N and Cobb J. (2008). Managing acrometastases treatment strategy with a case illustration. Ann R Coll Surg Engl 90(7): W8.
Google Scholar, Crossref, Indexed at
[3] Hayden RJ, Sullivan LG and Jebson PJ. (2004). The hand in metastatic disease and acral manifestations of paraneoplastic syndromes. Hand Clin 20(3): 335-343.
Awards Nomination
